Anna is from England and recently finished her undergraduate degree. She has an interest in medicine and enjoys writing. In her spare time she likes to cook, hike, and hang out with cats.

    The FDA has Approved a New Cancer Drug Called Copiktra™ (duvelisib)
    qimono / Pixabay

    The FDA has Approved a New Cancer Drug Called Copiktra™ (duvelisib)

    The United States Food and Drug Administration has approved Copiktra™ (duvelisib). The drug is now approved as a treatment for adult patients diagnosed with refractory or relapsed chronic lymphocytic leukaemia…

    Continue Reading The FDA has Approved a New Cancer Drug Called Copiktra™ (duvelisib)

    A Study of a Potential Drug for Primary Biliary Cholangitis has Exceeded its Patient Enrolment Target

    The company Genkyotex has announced that they have finished enrolling participants for a Phase 2 clinical trial of the investigational drug GKT831 in patients who have primary biliary cholangitis. The…

    Continue Reading A Study of a Potential Drug for Primary Biliary Cholangitis has Exceeded its Patient Enrolment Target
    Data from Studies of a Potential Drug for Spinal Muscular Atrophy Show Very Encouraging Results
    rawpixel / Pixabay

    Data from Studies of a Potential Drug for Spinal Muscular Atrophy Show Very Encouraging Results

    Encouraging interim data has been shared from two studies of risdiplam (RG7916), a drug being researched as a potential treatment for spinal muscular atrophy types 1, 2, and 3. For…

    Continue Reading Data from Studies of a Potential Drug for Spinal Muscular Atrophy Show Very Encouraging Results
    The FDA has Granted Orphan Drug Status to Q-Cells® for the Treatment of Transverse Myelitis
    stevepb / Pixabay

    The FDA has Granted Orphan Drug Status to Q-Cells® for the Treatment of Transverse Myelitis

    The United States Food and Drug Administration has awarded Orphan Drug Designation to Q-Cells®, a product being developed by Q Therapeutics, for the treatment of transverse myelitis. For more detailed…

    Continue Reading The FDA has Granted Orphan Drug Status to Q-Cells® for the Treatment of Transverse Myelitis
    New Updates on Patients Taking Part in Studies of a Gene Therapy for Fabry Disease Have Been Released
    jarmoluk / Pixabay

    New Updates on Patients Taking Part in Studies of a Gene Therapy for Fabry Disease Have Been Released

    Avrobio has released updates on patients in two clinical trials of a potential gene therapy for Fabry disease. According to the announcement, two patients taking part in a Phase 1…

    Continue Reading New Updates on Patients Taking Part in Studies of a Gene Therapy for Fabry Disease Have Been Released
    Ultragenyx has Released Updates on Their Study of a Potential Gene Therapy for OTC Deficiency
    mcmurryjulie / Pixabay

    Ultragenyx has Released Updates on Their Study of a Potential Gene Therapy for OTC Deficiency

    Ultragenyx Pharmaceuticals has shared data from two cohorts taking part in an on-going study involving an investigational gene therapy for ornithine transcarbamylase deficiency. For more information, you can view the…

    Continue Reading Ultragenyx has Released Updates on Their Study of a Potential Gene Therapy for OTC Deficiency
    Encouraging Topline Data has Been Shared From a Phase 3 Study of a Drug for Acute Hepatic Porphyria
    source: pixabay.com

    Encouraging Topline Data has Been Shared From a Phase 3 Study of a Drug for Acute Hepatic Porphyria

    Topline results have been shared from a Phase 3 study of the investigational drug givosiran in patients with acute hepatic porphyria. For more detailed information you can view the source…

    Continue Reading Encouraging Topline Data has Been Shared From a Phase 3 Study of a Drug for Acute Hepatic Porphyria

    Two Phase 2 Clinical Studies of a Drug for Rare Epilepsies Have Been Initiated

    Two Phase 2 clinical trials called ‘Elektra’ and ‘Arcade’ have been initiated. They will investigate the drug OV935/TAK-935 as a potential treatment for paediatric patients with rare epilepsies. For more…

    Continue Reading Two Phase 2 Clinical Studies of a Drug for Rare Epilepsies Have Been Initiated
    New Tools are Being Developed to Help Understand the Genetic Causes of Early Infantile Epileptic Encephalopathy
    blickpixel / Pixabay

    New Tools are Being Developed to Help Understand the Genetic Causes of Early Infantile Epileptic Encephalopathy

    Researchers at the University of Utah are working on developing computational tools that can be used to help identify the genetic changes underlying early infantile epileptic encephalopathy. For more detailed…

    Continue Reading New Tools are Being Developed to Help Understand the Genetic Causes of Early Infantile Epileptic Encephalopathy
    Avrobio Plans to Go Ahead with a Phase 1/2 Study of a Gene Therapy in Gaucher Disease
    Philippedelavie / Pixabay

    Avrobio Plans to Go Ahead with a Phase 1/2 Study of a Gene Therapy in Gaucher Disease

    Avrobio has received no objection from Health Canada for their clinical trial application for their Phase 1/2 study of an investigational gene therapy for Gaucher disease. Following this news, Avrobio…

    Continue Reading Avrobio Plans to Go Ahead with a Phase 1/2 Study of a Gene Therapy in Gaucher Disease
    Shriners Hospitals for Children® are Using Motion Analysis Centres to Help Understand Patients’ Movements
    geralt / Pixabay

    Shriners Hospitals for Children® are Using Motion Analysis Centres to Help Understand Patients’ Movements

    Shriners Hospitals for Children® has announced their motion analysis centre consortium. The hospital’s Motion Analysis Centre is used to evaluate the movements and gait of children and teenagers. To read about…

    Continue Reading Shriners Hospitals for Children® are Using Motion Analysis Centres to Help Understand Patients’ Movements
    Preliminary Data from a Phase 1/2 Study of a Gene Therapy for X-Linked Retinitis Pigmentosa has been Shared
    Free-Photos / Pixabay

    Preliminary Data from a Phase 1/2 Study of a Gene Therapy for X-Linked Retinitis Pigmentosa has been Shared

    Nightstar Therapeutics has released preliminary data from a Phase 1/2 study of an experimental gene therapy designed to treat X-linked retinitis pigmentosa. For more detailed information you can view the…

    Continue Reading Preliminary Data from a Phase 1/2 Study of a Gene Therapy for X-Linked Retinitis Pigmentosa has been Shared

    Researchers are Looking into How RNA Affects Parkinson’s Disease and Psychiatric Disorders

    A study carried out by researchers from Harvard Medical School and Brigham and Women’s Hospital has explored the link between dopamine neurones, Parkinson’s disease, and psychiatric disorders. To read about…

    Continue Reading Researchers are Looking into How RNA Affects Parkinson’s Disease and Psychiatric Disorders
    The FDA Has Awarded Orphan Drug Designation to a Therapy for Complications After Haematopoietic Cell Transplantation
    qimono / Pixabay

    The FDA Has Awarded Orphan Drug Designation to a Therapy for Complications After Haematopoietic Cell Transplantation

    The United States Food and Drug Administration has awarded Orphan Drug Designation to an experimental PLX cell therapy (called PLX-R18) as a treatment for graft failure and incomplete haematopoietic recovery…

    Continue Reading The FDA Has Awarded Orphan Drug Designation to a Therapy for Complications After Haematopoietic Cell Transplantation
    Preliminary Data from a Phase 1/2 Study of a Gene Therapy for Haemophilia A has been Shared
    Bru-nO / Pixabay

    Preliminary Data from a Phase 1/2 Study of a Gene Therapy for Haemophilia A has been Shared

    Sangamo Therapeutics has shared details of their preliminary data from a clinical trial of the investigational drug SB-525 in patients with Haemophilia A. For more detailed information, you can read…

    Continue Reading Preliminary Data from a Phase 1/2 Study of a Gene Therapy for Haemophilia A has been Shared

    A Group of Disorders Share Similarities in Their DNA 3D Folding Patterns, Researchers Say

    Researchers at the University of Pennsylvania have studied the genetics of a class of neurological disorders that includes Huntington’s disease and Fragile X Syndrome. They found that there were similarities…

    Continue Reading A Group of Disorders Share Similarities in Their DNA 3D Folding Patterns, Researchers Say
    Amicus Therapeutics and the FDA Have Met to Discuss the Path for a Potential Pompe Disease Therapy
    889520 / Pixabay

    Amicus Therapeutics and the FDA Have Met to Discuss the Path for a Potential Pompe Disease Therapy

      Amicus Therapeutics has met with the United States Food and Drug Administration to discuss the investigational drug AT-GAA, which is being researched as a potential treatment for Pompe disease.…

    Continue Reading Amicus Therapeutics and the FDA Have Met to Discuss the Path for a Potential Pompe Disease Therapy